Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Case | CASE | Nov 22, 2024 | 16.80 | +1.82 |
Castellum | CAST | Nov 22, 2024 | 125.05 | +2.37 |
Catella A | CATA | Nov 22, 2024 | 28.00 | -7.28 |
Catella B | CATB | Nov 22, 2024 | 28.15 | 0.00 |
Catena | CATE | Nov 22, 2024 | 487.00 | +2.74 |
Catena Media | CTM | Nov 22, 2024 | 4.54 | +2.25 |
Cavendish Hydrogen | CAVENO | Nov 22, 2024 | 9.65 | -3.02 |
Cavotec SA | CCC | Nov 22, 2024 | 17.55 | +5.41 |
CDON | CDON | Nov 22, 2024 | 97.60 | +3.83 |
Cedergrenska | CEDER | Nov 22, 2024 | 28.40 | +2.90 |
Cell Impact | CI | Nov 22, 2024 | 0.18 | +2.86 |
CellaVision | CEVI | Nov 22, 2024 | 217.00 | +1.17 |
Cereno Scientific B | CRNOB | Nov 22, 2024 | 4.93 | +0.57 |
ChargePanel AB (publ) | CHARGE | Nov 22, 2024 | 1.48 | -0.67 |
Checkin.com Group | CHECK | Nov 22, 2024 | 18.45 | +7.89 |
Cheffelo | CHEF | Nov 22, 2024 | 24.90 | +0.40 |
Chordate Medical Holding | CMH | Nov 22, 2024 | 20.40 | -1.92 |
Chosa Oncology AB | CHOSA | Nov 22, 2024 | 0.80 | 0.00 |
ChromoGenics | CHRO | Nov 22, 2024 | 9.78 | 0.00 |
Cibus Nordic Real Estate | CIBUS | Nov 22, 2024 | 170.55 | +2.28 |
Cinclus Pharma Holding AB | CINPHA | Nov 22, 2024 | 20.01 | +1.80 |
Cinis Fertilizer AB | CINIS | Nov 22, 2024 | 14.48 | +0.98 |
Cint Group | CINT | Nov 22, 2024 | 12.10 | +4.04 |
CirChem | CIRCHE | Nov 22, 2024 | 2.84 | -3.40 |
Circle Energy Sweden B | CIRCLEB | Nov 22, 2024 | 0.00 | 0.00 |
Clas Ohlson B | CLASB | Nov 22, 2024 | 191.60 | +2.19 |
Clavister Holding | CLAV | Nov 22, 2024 | 1.81 | -0.82 |
Clean Motion | CLEMO | Nov 22, 2024 | 0.34 | -4.47 |
Clemondo Group | CLEM | Nov 22, 2024 | 0.78 | +1.57 |
Climeon B | CLIMEB | Nov 22, 2024 | 0.33 | +2.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.